Avapritinib (Standard)
Avapritinib (Standard) is the analytical standard of Avapritinib. This product is intended for research and analytical applications. Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98%
- No. CAS: 1703793-34-3
- Fòrmula: C26H27FN10
- Peso molecular:498.56
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-101561
AvapritinibKIT/PDGFRA Inhibitor -
HY-15463
ImatinibTyrosine Kinases Inhibitor -
HY-16749
PexidartinibCSF1R/c-Kit Inhibitor -
HY-112306
RipretinibKIT/PDGFRA Inhibitor -
HY-101443
ISCK03SCF/c-Kit Inhibitor -
HY-50946
Imatinib Mesylatec-Kit Inhibitor -
HY-10527
TelatinibVEGFR/PDGFα/c-Kit Inhibitor -
HY-10228
MotesanibVEGFR1/2/3 Inhibitor -
HY-13894
Tyrphostin AG1296PDGFR Inhibitor -
HY-15463R
Imatinib (Standard)Tyrosine Kinases Inhibitor -
HY-50905
DovitinibMultiple RTK Inhibitor -
HY-12050
CP-673451PDGFR Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 1703793-34-3
-
Peso molecular 498.56
-
Fòrmula C26H27FN10
-
SMILES
CN1N=CC(C2=CN3C(C(N4CCN(C5=NC=C([C@@](C)(N)C6=CC=C(F)C=C6)C=N5)CC4)=NC=N3)=C2)=C1
-
Synonyms
BLU-285 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Wu CP, et al. Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-MediatedMultidrug Resistance in Cancer Cell Lines. Mol Pharm. 2019 Jul 1;16(7):3040-3052. [Content Brief]
[2]. Evans EK, et al. A precision therapy against cancers driven by KIT/PDGFRA mutations. Sci Transl Med. 2017 Nov 1;9(414). pii: eaao1690. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Avapritinib (Standard) Related Classifications
HY-101561R Related Classifications
Powered by Bioz